IR-News

AUSSENDER



Medigene AG
Ansprechpartner: Medigene PR/IR
Tel.: +49 89 2000 33 3301
E-Mail: investor@medigene.com

WEITERE IR-NEWS

pta20180830038
Release according to article 40 para. 1 WpHG

Medigene AG: Release according to Article 40, Section 1 of the WpHG

Voting Rights Announcement

Planegg (pta038/30.08.2018/14:00) - Release of Voting Rights Announcement

Voting Rights Announcement

1. Details of issuer:

Name: Medigene AG
Legal Entity Identifier (LEI): 391200I33JD2DKZGDX06
Street: Lochhamer Straße 11
Postal code: 82152
City: Planegg, Germany

2. Reason for notification:
Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation
Legal entity: Aviva plc
City of registered office, country: London, United Kingdom

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3
Aviva Life & Pensions UK Limited

5. Date on which threshold was crossed or reached
28.08.2018

6. Total positions

% of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG
New 5.06 0.15 5.21 24,554,012
Previous notification (if applicable) 4.96 0.34 5.30

7. Details on total positions

a. Voting rights attached to shares (Sec.s 33, 34 WpHG)

ISIN Absolute direct (Sec. 33 WpHG) Absolute indirect (Sec. 34 WpHG) In % direct (Sec. 33 WpHG) In % indirect (Sec. 34 WpHG)
DE000A1X3W00 0 1,241,512 0.00 5.06
Total: 1,241,512 5.06

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Voting Rights Absolute Voting Rights in %
Right to recall loaned shares 36,395 0.15
Total: 36,395 0.15

b.2 Instruments according to Sec. 38 (1) no. 2 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Cash or physical transaction Voting Rights Absolute Voting Rights in %
Total:

8. Information in relation to the person subject to the notification obligation

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
Aviva plc
Aviva Group Holdings Limited
Aviva France SA
--
Aviva plc
Aviva Group Holdings Limited
Aviva Life Holdings UK Limited
Aviva Life & Pensions UK Limited 4.12
--
Aviva plc
Aviva Group Holdings Limited
Aviva Investors Holdings Limited
Aviva Investors Global Services Limited 5.06 5.21
--
Aviva plc
Aviva Group Holdings Limited
Aviva Investors Holdings Limited
Friends Life Funds Limited

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting: N/A

10. Other useful information


Date Signature
N/A N/A

(end)
emitter: Medigene AG
Lochhamer Straße 11
82152 Planegg
Germany
contact person: Medigene PR/IR
phone: +49 89 2000 33 3301
e-mail: investor@medigene.com
website: www.medigene.de
stock exchanges: regulated market in Frankfurt; free market in Dusseldorf, free market in Hamburg, free market in Hannover, free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
ISIN(s): DE000A1X3W00
|
|
98.234 Abonnenten
|
167.461 Meldungen
|
66.237 Pressefotos

BUSINESS

16.11.2018 - 13:15 | Vogel Communications Group GmbH & Co. KG
16.11.2018 - 10:30 | pressetext.redaktion
16.11.2018 - 06:05 | pressetext.redaktion
15.11.2018 - 18:50 | Pöhacker Sabine - comm:unications
15.11.2018 - 12:36 | pressetext.redaktion
Top